Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression

Citation
Ef. Branigan et Ma. Estes, Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression, FERT STERIL, 73(3), 2000, pp. 587-590
Citations number
17
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
FERTILITY AND STERILITY
ISSN journal
00150282 → ACNP
Volume
73
Issue
3
Year of publication
2000
Pages
587 - 590
Database
ISI
SICI code
0015-0282(200003)73:3<587:MSIUCC>2.0.ZU;2-I
Abstract
Objective: To determine if oral contraceptive pill (OC) pre-treatment prior to minimal stimulation IVF using clomiphene citrate (CC) would make the pr ocedure easier to perform by preventing the LH surge and result in pregnanc y rates (PRs) comparable to stimulated IVF. Design: Prospective cohort study. Setting: Private tertiary infertility center. Patient(s): Thirty-two women with tubal or pelvic adhesive disease as the c ause of their infertility, ovulatory cycles, under the age of 40, and no ma le factor. Intervention(s): Two-month ovarian-hypothalamic-pituitary axis s uppression with OC followed by CC 100 mg on day 3 of the cycle for 8 days, hCG administration midcycle, follicle aspiration, NF, and embryo transfer. Main Outcome Measure(s): Oocytes retrieved, serum LH and estradiol levels, maturity of oocytes, fertilization rates, embryo number and quality, and PR s. Result(s): Thirty-six patients completed 71 stimulation cycles and 64 folli cle aspirations. No LH surges occurred with a mean mature oocytes retrieved of 3.2, 90% fertilization rate, and mean 2.5 embryos transferred. Twenty-o ne of the 64 cycles resulted in a clinical pregnancy (32.8% PR per retrieva l) with 2 other biochemical pregnancies and 3 twin gestations. This was not significantly different from the matched cohort stimulated IVF. Conclusion(s): Minimal stimulation IVF is a simple, low-cost, and low-risk alternative to stimulated IVF with comparable PRs. (C) 2000 by American Soc iety for Reproductive Medicine.